BioVie Stock Forecast

Stock Price Forecast

According to 2 analysts polled by S&P Global, BioVie stock has a consensus rating of "Strong Buy" and an average price target of $5.26. The average 1-year stock price forecast is 246.05% higher than the current stock price, while the lowest is $5.00 (+228.95%) and the highest is $5.51 (+262.50%).

Price Target: $5.26 (+246.05%)

Analyst Consensus: Strong Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$5.00	$5.26	$5.26	$5.51
Change	+228.95%	+246.05%	+246.05%	+262.50%

Analyst Ratings

The average analyst rating for BioVie stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart

Rating	Apr '25	May '25	Aug '25	Nov '25	Jun '26	Jul '26
Strong Buy	1	1	1	1	1	2
Buy	0	0	0	0	0	0
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	1	1	1	1	1	2

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

n/a

EPS This Year

-1.19

from -12.12

EPS Next Year

-0.63

from -1.19

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Jun 30, 2021	Jun 30, 2022	Jun 30, 2023	Jun 30, 2024	Jun 30, 2025	Jun 30, 2026
Revenue	-	-	-	-	-	-
Operating Income	-138.05M	-27.25M	-45.08M	-32.18M	-18.07M	-22.50M
Net Income	-130.25M	-26.08M	-50.26M	-32.12M	-17.54M	-22.20M
EPS	-	-	-	-	-12.12	-1.19
Free Cash Flow	-104.78M	-8.77M	-22.84M	-18.78M	-13.13M	-79.61M
No. Analysts	-	-	-	-	-	1

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	n/a
Avg	n/a
Low	n/a

Revenue Growth

Chart

Revenue Growth	2027	2028
High	-
Avg	-
Low	-

EPS Forecast

Chart

EPS	2026	2027	2028
High	-1.19
Avg	-1.19
Low	-1.19

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-